Daiichi Sankyo Initiates Phase 1 Study of U3-1402 in Patients with Metastatic EGFR-Mutated Non-Small Cell Lung Cancer
Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo) announced that the first patient has been dosed in a phase 1 study...
Allergan Announces Positive Top Line Phase 3 Results for Ubrogepant – an Oral CGRP Receptor Antagonist for the Acute Treatment of Migraine.
Allergan plc , a leading global pharmaceutical company today announced positive results from ACHIEVE I (UBR-MD-01), the first of two...
Global Women’s Health Divestiture to CVC Capital Partners completed declares Teva
Teva Pharmaceutical Industries Ltd. announced it has completed the sale of a portfolio of products within its global women’s health...
Teva Completes Amendment to Credit Facilities
Teva Pharmaceutical Industries Ltd. announced amendments to its USD and JPY term loan and revolving credit facilities, providing the company...
Accepts Fremanezumab Marketing Authorization Application Accepted by European Medicines Agency (EMA)
Teva Pharmaceutical Industries Ltd., announced that the European Medicines Agency (EMA) has accepted the Marketing Authorization Application (MAA) for fremanezumab,...
MRSA infections can be protected by Immune system: Research
After years of investigation, researchers at Johns Hopkins, the University of California, Davis, and the National Institute of Allergy and...
Guidelines extended to improve the use of feedback from patients in clinical trials.
Researchers recommend changes to international guidelines used in the development of clinical trials in an effort to obtain useful information...
Novartis compound to fight Alzheimer’s disease shows potential.
Novartis Compound designed to fight Alzheimer’s disease shows positive signs in the lab. The molecule is restoring the activity of...
Top Employer”2018- Sanofi
Sanofi Recognized by Top Employers Institute for Good Practice in Employee Development.Sanofi has been officially certified today as a 2018...
High levels of antibiotic resistance found worldwide, new data shows
WHO’s first release of surveillance data on antibiotic resistance reveals high levels of resistance to a number of serious bacterial...
About Us
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.